Rudranil De

Rudranil De

Auto-generated profile, based on publicly available information

Rudranil De

Amity Institute of Biotechnology, Amity University, Kolkata, India

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SMSomnath Mazumder
Somnath Mazumder
RDRudranil De
Rudranil De
SDSubhashis Debsharma
Subhashis Debsharma
SBSamik Bindu
Samik Bindu
PMPallab Maity
Pallab Maity
UBUday Bandyopadhyay
Uday Bandyopadhyay
The subcellular mechanism by which nonsteroidal anti-inflammatory drugs (NSAIDs) induce apoptosis in gastric cancer and normal mucosal cells is elusive because of the diverse cyclooxygenase-independent effects of these drugs. Using human gastric carcinoma cells (AGSs) and a rat gastric injury model, here we report that the NSAID indomethacin activates the protein kinase Cζ (PKCζ)–p38 MAPK (p38)–dynamin-related protein 1 (DRP1) pathway and thereby disrupts the physiological balance of mitochondrial dynamics by promoting mitochondrial hyper-fission and dysfunction leading to apoptosis. Notably, DRP1 knockdown or SB203580-induced p38 inhibition reduced indomethacin-induced damage to AGSs. Indomethacin impaired mitochondrial dynamics by promoting fissogenic activation and mitochondrial recruitment of DRP1 and down-regulating fusogenic optic atrophy 1 (OPA1) and mitofusins in rat gastric mucosa. Consistent with OPA1 maintaining cristae architecture, its down-regulation resulted in EM-detectable cristae deformity. Deregulated mitochondrial dynamics resulting in defective mitochondria were evident from enhanced Parkin expression and mitochondrial proteome ubiquitination. Indomethacin ultimately induced mitochondrial metabolic and bioenergetic crises in the rat stomach, indicated by compromised fatty acid oxidation, reduced complex I– associated electron transport chain activity, and ATP depletion. Interestingly, Mdivi-1, a fission-preventing mito-protective drug, reversed indomethacin-induced DRP1 phosphorylation on Ser-616, mitochondrial proteome ubiquitination, and mitochondrial metabolic crisis. Mdivi-1 also prevented indomethacin-induced mitochondrial macromolecular damage, caspase activation, mucosal inflammation, and gastric mucosal injury. Our results identify mitochondrial hyper-fission as a critical and common subcellular event triggered by indomethacin that promotes apoptosis in both gastric cancer and normal mucosal cells, thereby contributing to mucosal injury.

1 July 2016 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
SSSouvik Sarkar
Souvik Sarkar
ASAsim A. Siddiqui
Asim A. Siddiqui
SSShubhra J. Saha
Shubhra J. Saha
RDRudranil De
Rudranil De
SMSomnath Mazumder
Somnath Mazumder
UBUday Bandyopadhyay
Uday Bandyopadhyay
We synthesized a new series of conjugated hydrazones that were found to be active against malaria parasite in vitro , as well as in vivo in a murine model. These hydrazones concentration-dependently chelated free iron and offered antimalarial activity. Upon screening of the synthesized hydrazones, compound 5f was found to be the most active iron chelator, as well as antiplasmodial. Compound 5f also interacted with free heme ( K D [equilibrium dissociation constant] = 1.17 ± 0.8 μM), an iron-containing tetrapyrrole released after hemoglobin digestion by the parasite, and inhibited heme polymerization by parasite lysate. Structure-activity relationship studies indicated that a nitrogen- and sulfur-substituted five-membered aromatic ring present within the benzothiazole hydrazones might be responsible for their antimalarial activity. The dose-dependent antimalarial and heme polymerization inhibitory activities of the lead compound 5f were further validated by following [ 3 H]hypoxanthine incorporation and hemozoin formation in parasite, respectively. It is worth mentioning that compound 5f exhibited antiplasmodial activity in vitro against a chloroquine/pyrimethamine-resistant strain of Plasmodium falciparum (K1). We also evaluated in vivo antimalarial activity of compound 5f in a murine model where a lethal multiple-drug-resistant strain of Plasmodium yoelii was used to infect Swiss albino mice. Compound 5f significantly suppressed the growth of parasite, and the infected mice experienced longer life spans upon treatment with this compound. During in vitro and in vivo toxicity assays, compound 5f showed minimal alteration in biochemical and hematological parameters compared to control. In conclusion, we identified a new class of hydrazone with therapeutic potential against malaria.

5 December 2022 in Biochemical Pharmacology
Verified
Journal Article
Closed access
SDSrijan Dubey
Srijan Dubey
SGSayak Ghosh
Sayak Ghosh
DGDebosmita Goswami
Debosmita Goswami
DGDebapriya Ghatak
Debapriya Ghatak
RDRudranil De
Rudranil De

29 October 2022 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
CBChandan Bhowal
Chandan Bhowal
SGSayak Ghosh
Sayak Ghosh
DGDebapriya Ghatak
Debapriya Ghatak
RDRudranil De
Rudranil De

1 December 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
RDRudranil De
Rudranil De
SSSouvik Sarkar
Souvik Sarkar
SMSomnath Mazumder
Somnath Mazumder
SDSubhashis Debsharma
Subhashis Debsharma
ASAsim Azhar Siddiqui
Asim Azhar Siddiqui
UBUday Bandyopadhyay
Uday Bandyopadhyay
The indispensable role of macrophage migration inhibitory factor (MIF) in cancer cell proliferation is unambiguous, although which specific roles the cytokine plays to block apoptosis by preserving cell growth is still obscure. Using different cancer cell lines (AGS, HepG2, HCT116, and HeLa), here we report that the silencing of MIF severely deregulated mitochondrial structural dynamics by shifting the balance toward excess fission, besides inducing apoptosis with increasing sub-G0 cells. Furthermore, enhanced mitochondrial Bax translocation along with cytochrome c release, down-regulation of Bcl-xL, and Bcl-2 as well as up-regulation of Bad, Bax, and p53 indicated the activation of a mitochondrial pathway of apoptosis upon MIF silencing. The data also indicate a concerted down-regulation of Opa1 and Mfn1 along with a significant elevation of Drp1, cumulatively causing mitochondrial fragmentation upon MIF silencing. Up-regulation of Drp1 was found to be further coupled with fissogenic serine 616 phosphorylation and serine 637 dephosphorylation, thus ensuring enhanced mitochondrial translocation. Interestingly, MIF silencing was found to be associated with decreased NF-κB activation. In fact, NF-κB knockdown in turn increased mitochondrial fission and cell death. In addition, the silencing of CD74, the cognate receptor of MIF, remarkably increased mitochondrial fragmentation in addition to preventing cell proliferation, inducing mitochondrial depolarization, and increasing apoptotic cell death. This indicates the active operation of a MIF-regulated CD74–NF-κB signaling axis for maintaining mitochondrial stability and cell growth. Thus, we propose that MIF, through CD74, constitutively activates NF-κB to control mitochondrial dynamics and stability for promoting carcinogenesis via averting apoptosis.

17 October 2020 in Cell Biology and Toxicology
Verified
Journal Article
Closed access
PDF file
RDRudranil De
Rudranil De
SMSomnath Mazumder
Somnath Mazumder
UBUday Bandyopadhyay
Uday Bandyopadhyay